Evaluation of Esophageal Motility and Lessons from Chicago Classification version 4.0.


Journal

Current gastroenterology reports
ISSN: 1534-312X
Titre abrégé: Curr Gastroenterol Rep
Pays: United States
ID NLM: 100888896

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 28 1 2022
medline: 5 3 2022
entrez: 27 1 2022
Statut: ppublish

Résumé

Chicago Classification has standardized clinical approach to primary esophageal motility disorders. With new clinical data and advancing treatments, Chicago Classification has undergone multiple revisions to reflect updated findings and enhance diagnostic accuracy. This review will describe the recently published Chicago Classification version 4.0 (CCv4.0), which aimed to enhance diagnostic characterization and limit overdiagnosis of inconclusive esophageal motility diagnoses. Key revisions outlined in CCv4.0 include (1) a modified standardized HRM study protocol performed in supine and upright positions, (2) recommended ancillary testing and manometric provocation for inconclusive manometric diagnoses (3) the required presence of obstructive symptoms for conclusive diagnoses of esophagogastric junction outflow obstruction, distal esophageal spasm and hypercontractile esophagus, and (4) requirement of confirmatory testing for esophagogastric junction outflow obstruction. These key modifications aim to improve diagnostic accuracy and consistency of clinically relevant esophageal motility disorders, and subsequently clinical outcomes.

Identifiants

pubmed: 35084643
doi: 10.1007/s11894-022-00836-7
pii: 10.1007/s11894-022-00836-7
pmc: PMC9380285
mid: NIHMS1828006
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-17

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK125266
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK125266
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Neurogastroenterol Motil. 2015 Feb;27(2):160-74
pubmed: 25469569
Am J Gastroenterol. 2021 Feb 1;116(2):263-273
pubmed: 33273259
Neurogastroenterol Motil. 2009 Aug;21(8):796-806
pubmed: 19413684
Dis Esophagus. 2017 Dec 1;30(12):1-6
pubmed: 28881880
Am J Gastroenterol. 2015 Jul;110(7):979-84
pubmed: 26032150
J Clin Gastroenterol. 2021 May-Jun 01;55(5):369-379
pubmed: 33337637
Gastroenterology. 2013 Apr;144(4):718-25; quiz e13-4
pubmed: 23277105
Neurogastroenterol Motil. 2021 Jan;33(1):e14058
pubmed: 33373111
Neurogastroenterol Motil. 2021 Jan;33(1):e14053
pubmed: 33340190
World J Gastroenterol. 2019 Jan 28;25(4):411-417
pubmed: 30700938
Dis Esophagus. 2015 Nov-Dec;28(8):711-9
pubmed: 25185507
J Clin Gastroenterol. 2008 May-Jun;42(5):627-35
pubmed: 18364587
Neurogastroenterol Motil. 2012 Mar;24 Suppl 1:57-65
pubmed: 22248109
Dis Esophagus. 2017 Dec 1;30(12):1-7
pubmed: 28881883
Gastroenterology. 2008 Nov;135(5):1526-33
pubmed: 18722376
Neurogastroenterol Motil. 2017 Jul;29(7):
pubmed: 28229560
Digestion. 2017;95(1):29-35
pubmed: 28052278
Curr Gastroenterol Rep. 2014 Dec;16(12):420
pubmed: 25543338
J Neurogastroenterol Motil. 2011 Jan;17(1):48-53
pubmed: 21369491

Auteurs

Priya Sharma (P)

Department of Medicine, University of California, San Diego, La Jolla, CA, USA.

Rena Yadlapati (R)

Division of Gastroenterology, University of California, San Diego, ACTRI, Building 1W517, 9500 Gilman Drive MC 0956, La Jolla, CA, 92093, USA. ryadlapati@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH